Solid Biosciences Inc. SLDB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $155.55M+43.4% | $140.33M+45.5% | $132.96M+63.9% | $121.43M+72.3% | $108.47M+53.2% | ||
| $40.91M+18.8% | $38.88M+16.8% | $36.74M+18.6% | $35.4M+19.8% | $34.45M+21.5% | ||
| $196.46M+37.5% | $179.21M+38.1% | $169.7M+51.4% | $156.82M+56.8% | $142.92M+44.2% | ||
| -$196.46M-37.5% | -$179.21M-38.1% | -$169.7M-51.4% | -$156.82M-56.8% | -$142.92M-44.2% | ||
| —— | -$208K-161% | -$133K-136% | $285K-26.9% | $313K-24.2% | ||
| $5.07M— | $5.27M— | —— | —— | —— | ||
| -$191.78M-37.3% | -$174.33M-39.8% | -$167.14M-63.2% | -$154.08M-69.9% | -$139.68M-54.8% | ||
| -$1.95+35.2% | -$2.02+34.0% | -$2.51+17.4% | -$2.82+14.5% | -$3.01+23.6% | ||
| -$194.84M-38.8% | -$177.57M-39.5% | -$168.04M-53.5% | -$155.14M-59.6% | -$140.38M-45.0% | ||
| -$196.46M-37.5% | -$179.21M-38.1% | -$169.7M-51.4% | -$156.82M-56.8% | -$142.92M-44.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Solid Biosciences Inc.'s revenue?
- Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.
- Is Solid Biosciences Inc. profitable?
- Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.
- What is Solid Biosciences Inc.'s earnings per share?
- Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.
- Where does Solid Biosciences Inc.'s income statement data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
